Targeting Cancer with Antibody-drug Conjugates » ADC Review sorted by
relevance

Admin23.07.2021

Targeting Cancer with Antibody-drug Conjugates » ADC Review

9700
Admin01.08.2021

Figure 1 from Antibody-drug conjugates: recent advances in

8201
Admin14.08.2021

ADC technology

97010
Admin14.07.2021

Antibody-Drug Conjugate (ADC) and Cancer Therapy

32010
Admin23.09.2021

[PDF] Antibody drug conjugates: Progress, pitfalls, and

6707
Admin24.08.2021

Pharmaceuticals | Free Full-Text | Antibody-Drug

3903
Admin15.07.2021

Antibody-drug Conjugate Development » ADC Review

2805
Admin14.09.2021

Antibody Drug Conjugates for Cancer Therapy

8203
Admin09.09.2021

The Clinical Landscape of Antibody-drug Conjugates - ADC

401
Admin27.09.2021

Biomedicines | Free Full-Text | Antibody-Drug Conjugates

36010
Admin21.08.2021

Antibodies | Free Full-Text | Antibody Drug Conjugates as

7308
Admin10.08.2021

CPhI Annual Report 2018: ADCs Growth Driven by Lack of In

5202
Admin12.08.2021

The ABCs of ADCs: A Review of Antibody Drug Conjugates

Admin04.08.2021

Antibody Drug Conjugates for Cancer Therapy

4105
Admin19.07.2021

Antibody-Drug Conjugates: Future Directions in Clinical

1805
Admin28.08.2021

[Full text] Antibody-drug conjugates: targeted weapons

6704
Admin25.08.2021

Seattle Genetics Launched the Phase II Clinical Trial of

2603
Admin20.09.2021

Schematic for the structure of an antibody-drug conjugate

37010
Admin06.10.2021

Targeting Cancer with Antibody-drug Conjugates » ADC Review

906
Admin21.09.2021

Antibodies | Free Full-Text | Antibody Drug Conjugates as

9809
Admin02.10.2021

Schematic illustration of antibody-drug conjugate (ADC

2306